| 1 | Managing the burden of incidental FDG‐avid thyroid nodules: New consensus statement | 2.5 | 0 | Citations (PDF) |
| 2 | Use of thyroid hormones in hypothyroid and euthyroid patients: A survey of members of the Endocrine Society of Australia | 2.5 | 10 | Citations (PDF) |
| 3 | Hypothyroidism and Type D Personality: Results From E-MPATHY, a Cross-sectional International Online Patient Survey | 4.5 | 10 | Citations (PDF) |
| 4 | Use of levothyroxine for euthyroid, thyroid antibody positive women with infertility: Analyses of aggregate data from a survey of European thyroid specialists (Treatment of Hypothyroidism in Europe by Specialists: An International Survey) | 2.5 | 8 | Citations (PDF) |
| 5 | Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration | 2.9 | 9 | Citations (PDF) |
| 6 | Thyroid hormones for euthyroid patients with simple goiter growing over time: a survey of European thyroid specialists | 2.6 | 7 | Citations (PDF) |
| 7 | Limiting the use and misuse of liothyronine in hypothyroidism | 25.2 | 9 | Citations (PDF) |
| 8 | The enigma of persistent symptoms in hypothyroid patients treated with levothyroxine: A narrative review | 2.5 | 57 | Citations (PDF) |
| 9 | Levothyroxine absorption test: A therapeutic strategy for improving medication adherence | 2.5 | 2 | Citations (PDF) |
| 10 | Inter-observer Variability of Clinical Activity Score: Assessments in Patients With Thyroid Eye Disease | 3.5 | 21 | Citations (PDF) |
| 11 | Hypothyroidism and Somatization: Results from E-Mode Patient Self-Assessment of Thyroid Therapy, a Cross-Sectional, International Online Patient Survey | 4.7 | 21 | Citations (PDF) |
| 12 | Characteristics of specialists treating hypothyroid patients: the “THESIS” collaborative | 4.0 | 5 | Citations (PDF) |
| 13 | Use of thyroid hormone in hypothyroid patients and euthyroid subjects in Spain: A THESIS* questionnaire survey | 0.5 | 16 | Citations (PDF) |
| 14 | Real-life practice of thyroid hormone use in hypothyroid and euthyroid patients: A detailed view from the THESIS questionnaire survey in France | 0.2 | 20 | Citations (PDF) |
| 15 | Primary hypothyroidism and quality of life | 25.2 | 112 | Citations (PDF) |
| 16 | Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS* survey of Belgian specialists *THESIS: treatment of hypothyroidism in Europe by specialists: an international survey | 1.5 | 19 | Citations (PDF) |
| 17 | Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic | 2.9 | 0 | Citations (PDF) |
| 18 | Postradioiodine Graves' management: The PRAGMA study | 2.5 | 12 | Citations (PDF) |
| 19 | A survey on the psychological impact and access to health care of thyroid patients during the first SARS‐COV‐2 lockdown | 2.5 | 10 | Citations (PDF) |
| 20 | Use of thyroid hormones in hypothyroid and euthyroid patients: a 2020 THESIS questionnaire survey of members of the Czech Society of Endocrinology | 3.0 | 16 | Citations (PDF) |
| 21 | A Questionnaire Survey of German Thyroidologists on the Use of
Thyroid Hormones in Hypothyroid and Euthyroid Patients: The THESIS (Treatment of
Hypothyroidism in Europe by Specialists: An International Survey)
Collaborative | 1.5 | 23 | Citations (PDF) |
| 22 | Enhanced Well-Being Associated with Thyrotoxicosis: A Neglected Effect of Thyroid Hormones? | 1.3 | 4 | Citations (PDF) |
| 23 | Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: A THESIS questionnaire survey of members of the Irish Endocrine Society | 1.3 | 13 | Citations (PDF) |
| 24 | New Formulations of Levothyroxine in the Treatment of Hypothyroidism: Trick or Treat? | 4.7 | 57 | Citations (PDF) |
| 25 | Patient satisfaction and quality of life in hypothyroidism: An online survey by the british thyroid foundation | 2.5 | 67 | Citations (PDF) |
| 26 | Use of thyroid hormones in hypothyroid and euthyroid patients: A 2020 THESIS questionnaire survey of members of the Danish Endocrine Society | 2.9 | 32 | Citations (PDF) |
| 27 | Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS* questionnaire survey of Polish physicians. *THESIS: Treatment of hypothyroidism in Europe by specialists: an international survey | 1.1 | 28 | Citations (PDF) |
| 28 | Use of thyroid hormones in hypothyroid and euthyroid patients: a 2020 THESIS questionnaire survey of members of the Hellenic Endocrine Society. | 2.0 | 21 | Citations (PDF) |
| 29 | Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: A 2020 THESIS Questionnaire Survey of Members of the Swedish Endocrine Society | 4.0 | 23 | Citations (PDF) |
| 30 | New Therapeutic Horizons for Graves’ Hyperthyroidism | 26.3 | 79 | Citations (PDF) |
| 31 | Asymmetric Graves’ Orbitopathy | 4.0 | 24 | Citations (PDF) |
| 32 | Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study | 2.9 | 33 | Citations (PDF) |
| 33 | Differentiated thyroid cancer mortality by disease stage in northern England | 2.5 | 4 | Citations (PDF) |
| 34 | Antithyroid drugs in Graves’ hyperthyroidism: differences between “block and replace” and “titration” regimes in frequency of euthyroidism and Graves’ orbitopathy during treatment | 2.9 | 11 | Citations (PDF) |
| 35 | Weight gain following treatment of hyperthyroidism—A forgotten tale | 2.0 | 44 | Citations (PDF) |
| 36 | Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study | 4.7 | 100 | Citations (PDF) |
| 37 | Thyroid Cancer 2019, , 557-579 | | 0 | Citations (PDF) |
| 38 | A survey of current practices by the British Oculoplastic Surgery Society (BOPSS) and recommendations for delivering a sustainable multidisciplinary approach to thyroid eye disease in the United Kingdom | 2.2 | 8 | Citations (PDF) |
| 39 | Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1 | 2.7 | 23 | Citations (PDF) |
| 40 | Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial | 13.2 | 190 | Citations (PDF) |
| 41 | Efficacy and safety of telotristat ethyl (TE) in combination with lanreotide (LAN) in patients with a neuroendocrine tumour and carcinoid syndrome (CS) diarrhoea (CSD): Meta-analysis of phase III double-blind placebo (PBO)-controlled TELESTAR and TELECAST studies | 1.2 | 1 | Citations (PDF) |
| 42 | The UK Evidence-Based Guidelines for the Management of Thyroid Cancer: Key Recommendations 2018, , 7-15 | | 1 | Citations (PDF) |
| 43 | A decade of thyroidology | 2.0 | 3 | Citations (PDF) |
| 44 | A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom | 2.2 | 33 | Citations (PDF) |
| 45 | Assessment of normal reference values for thyroid uptake of technetium-99m pertechnetate in a single centre UK population | 1.2 | 21 | Citations (PDF) |
| 46 | Tremelimumab-Induced Graves Hyperthyroidism | 2.3 | 53 | Citations (PDF) |
| 47 | Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit | 1.5 | 18 | Citations (PDF) |
| 48 | Improving the prehospital safety of steroid‐dependent patients in northern England: A hospital‐initiated ambulance service registration pathway | 2.5 | 3 | Citations (PDF) |
| 49 | Raising awareness of Graves' orbitopathy with early warning cards | 2.5 | 4 | Citations (PDF) |
| 50 | Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement | 3.3 | 151 | Citations (PDF) |
| 51 | Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee | 2.5 | 174 | Citations (PDF) |
| 52 | Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines | 1.1 | 222 | Citations (PDF) |
| 53 | Serum thyroglobulin in the monitoring of differentiated thyroid cancer | 1.3 | 17 | Citations (PDF) |
| 54 | Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study | 1.1 | 45 | Citations (PDF) |
| 55 | Hypothyroxinemia, Hyperthyrotropinemia, and Radioiodine: Partners in Crime Against Graves Orbitopathy? | 0.9 | 0 | Citations (PDF) |
| 56 | Diagnosis of Graves' Orbitopathy (DiaGO): Results of a Pilot Study to Assess the Utility of an Office Tool for Practicing Endocrinologists | 4.5 | 15 | Citations (PDF) |
| 57 | Management of patients with Graves’ orbitopathy: initial assessment, management outside specialised centres and referral pathways | 1.5 | 41 | Citations (PDF) |
| 58 | PREGO (presentation of Graves’ orbitopathy) study: changes in referral patterns to European Group On Graves’ Orbitopathy (EUGOGO) centres over the period from 2000 to 2012 | 3.9 | 120 | Citations (PDF) |
| 59 | Future Research in Graves' Orbitopathy: From Priority Setting to Trial Design Through Patient and Public Involvement | 4.7 | 8 | Citations (PDF) |
| 60 | Thyroglobulin in differentiated thyroid cancer | 1.2 | 34 | Citations (PDF) |
| 61 | Medical Management of Mild and Moderate to Severe Thyroid Eye Disease 2015, , 83-88 | | 0 | Citations (PDF) |
| 62 | Demonstration of thyrotropin binding sites in orbital connective tissue: Possible role in the pathogenesis of thyroid-associated ophthalmopathy | 2.9 | 4 | Citations (PDF) |
| 63 | Thyroid disease and male reproductive function | 2.9 | 36 | Citations (PDF) |
| 64 | Saving lives of in‐patients with adrenal insufficiency: implementation of an alert scheme within the Newcastle‐upon‐Tyne Hospitals e‐Prescribing platform | 2.5 | 9 | Citations (PDF) |
| 65 | Novel Thermal Imaging Analysis Technique for Detecting Inflammation in Thyroid Eye Disease | 4.5 | 23 | Citations (PDF) |
| 66 | Residual Adrenal Function in Autoimmune Addison's Disease: Improvement After Tetracosactide (ACTH<sub>1–24</sub>) Treatment | 4.5 | 34 | Citations (PDF) |
| 67 | Guidelines for the management of thyroid cancer | 2.5 | 1,094 | Citations (PDF) |
| 68 | The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines | 3.0 | 41 | Citations (PDF) |
| 69 | The effect of B cell depletion therapy on anti‐<scp>TSH</scp> receptor antibodies and clinical outcome in glucocorticoid‐refractory Graves' orbitopathy | 2.5 | 71 | Citations (PDF) |
| 70 | Use of Somatostatin Analogues in ObesityDrugs, 2012, 68, 1963-1973 | 9.1 | 26 | Citations (PDF) |
| 71 | Management plan and delivery of care in Graves’ ophthalmopathy patients | 5.4 | 7 | Citations (PDF) |
| 72 | Carcinoid Tumour in an Ileocystoplasty: A Reminder to Consider Native Bowel Disease in the Reconstructed Urinary Tract | 0.2 | 2 | Citations (PDF) |
| 73 | Rising Serum 25-Hydroxyvitamin D Levels After Weight Loss in Obese Women Correlate With Improvement in Insulin Resistance | 0.5 | 0 | Citations (PDF) |
| 74 | Clinical Spectrum of Graves Orbitopathy | 0.5 | 0 | Citations (PDF) |
| 75 | 2009 American Thyroid Association Guidelines on Thyroid Nodules | 1.4 | 6 | Citations (PDF) |
| 76 | Rising Serum 25-Hydroxy-Vitamin D Levels after Weight Loss in Obese Women Correlate with Improvement in Insulin Resistance | 4.5 | 144 | Citations (PDF) |
| 77 | The Amsterdam Declaration on Graves' Orbitopathy | 4.7 | 32 | Citations (PDF) |
| 78 | The Management of Hypogonadism in Aging Male Patients | 2.8 | 6 | Citations (PDF) |
| 79 | SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis | 1.8 | 61 | Citations (PDF) |
| 80 | Graves orbitopathy: a perspective | 25.2 | 15 | Citations (PDF) |
| 81 | Thyroid-Associated Orbitopathy: Who and How to Treat | 3.5 | 26 | Citations (PDF) |
| 82 | Thyroid eye disease | 0.1 | 85 | Citations (PDF) |
| 83 | Management of Graves’ orbitopathy in Latin America: an international questionnaire study compared with Europe | 2.5 | 17 | Citations (PDF) |
| 84 | Declaración de consenso del Grupo europeo sobre la orbitopatía de Graves (EUGOGO) sobre el tratamiento de la orbitopatía de Graves (OG) | 0.7 | 0 | Citations (PDF) |
| 85 | Erectile Dysfunction in Patients with Hyper- and Hypothyroidism: How Common and Should We Treat? | 4.5 | 112 | Citations (PDF) |
| 86 | Thyroid autoimmunity, infertility and miscarriage | 3.4 | 16 | Citations (PDF) |
| 87 | Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy | 4.7 | 363 | Citations (PDF) |
| 88 | Detection of Hurthle Cell Carcinoma Using Sestamibi | 4.7 | 4 | Citations (PDF) |
| 89 | Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey | 3.9 | 292 | Citations (PDF) |
| 90 | A Patient with Asymmetric Parotid Uptake on a Diagnostic Iodine-131 Scan during Thyroid Cancer Follow-Up | 4.7 | 2 | Citations (PDF) |
| 91 | A 52-Year-Old Female with a Hoarse Voice and Tingling in the Hand | 8.2 | 2 | Citations (PDF) |
| 92 | Milk alkali syndrome without the milk | 0.1 | 12 | Citations (PDF) |
| 93 | Genomic Polymorphism at the Interferon-Induced Helicase (IFIH1) Locus Contributes to Graves’ Disease Susceptibility | 4.5 | 106 | Citations (PDF) |
| 94 | Introduction to the updated guidelines on the management of thyroid cancer | 1.5 | 20 | Citations (PDF) |
| 95 | Cushing's syndrome without excess cortisol | 0.1 | 19 | Citations (PDF) |
| 96 | Pituitary Apoplexy: A Review of Clinical Presentation, Management and Outcome in 45 Cases | 3.0 | 286 | Citations (PDF) |
| 97 | Thyrotoxicosis and Pregnancy | 8.2 | 2 | Citations (PDF) |
| 98 | A 69-Year-Old Female with Tiredness and a Persistent Tan | 8.2 | 0 | Citations (PDF) |
| 99 | A Prospective Study of the Effects of Radioiodine Therapy for Hyperthyroidism in Patients with Minimally Active Graves’ Ophthalmopathy | 4.5 | 150 | Citations (PDF) |
| 100 | Early Response to Intravenous Glucocorticoids for Severe Thyroid-Associated Ophthalmopathy Predicts Treatment Outcome | 2.1 | 49 | Citations (PDF) |
| 101 | Influence of an Early-Onset Age of Type 1 Diabetes on Cerebral Structure and Cognitive Function | 9.6 | 227 | Citations (PDF) |
| 102 | Analysis of Peripheral Blood T-Cell Subsets in Active Thyroid-Associated Ophthalmopathy: Absence of Effect of Octreotide-LAR on T-Cell Subsets in Patients with Thyroid-Associated Ophthalmopathy | 4.7 | 6 | Citations (PDF) |
| 103 | Double-Blind, Placebo-Controlled Trial of Octreotide Long-Acting Repeatable (LAR) in Thyroid-Associated Ophthalmopathy | 4.5 | 85 | Citations (PDF) |
| 104 | Role of the CD40 Locus in Graves' Disease | 4.7 | 57 | Citations (PDF) |
| 105 | Serum Thyrotropin is a Better Predictor of Future Thyroid Dysfunction Than Thyroid Autoantibody Status in Biochemically Euthyroid Patients with Diabetes: Implications for Screening | 4.7 | 32 | Citations (PDF) |
| 106 | The Codon 620 Tryptophan Allele of the Lymphoid Tyrosine Phosphatase (LYP) Gene Is a Major Determinant of Graves’ Disease | 4.5 | 420 | Citations (PDF) |
| 107 | A New Assay for Thyrotropin Receptor Autoantibodies | 4.7 | 96 | Citations (PDF) |
| 108 | Multiple endocrine neoplasia type 2A | 1.0 | 13 | Citations (PDF) |
| 109 | Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma | 4.3 | 31 | Citations (PDF) |
| 110 | The Impact of Clinical Guidelines on Surgical Management in Patients with Thyroid Cancer | 1.4 | 11 | Citations (PDF) |
| 111 | Radioiodine Uptake in Normal Female Breasts and Liver of a Patient with Differentiated Thyroid Cancer Imaged by Whole Body Scanning | 4.7 | 5 | Citations (PDF) |
| 112 | Cognitive Ability and Brain Structure in Type 1 Diabetes | 0.5 | 283 | Citations (PDF) |
| 113 | Apolipoprotein-E Influences Aspects of Intellectual Ability in Type 1 Diabetes | 0.5 | 22 | Citations (PDF) |
| 114 | Medical Treatment for Thyroid-Associated Ophthalmopathy | 4.7 | 12 | Citations (PDF) |
| 115 | Orbital irradiation for thyroid-associated orbitopathy: conventional dose, low dose or no dose? | 2.5 | 11 | Citations (PDF) |
| 116 | Title is missing! | 3.0 | 6 | Citations (PDF) |
| 117 | Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment | 2.5 | 177 | Citations (PDF) |
| 118 | Lesson of the week: Deterioration of symptoms after start of thyroid hormone replacement | 0.1 | 37 | Citations (PDF) |
| 119 | Evidence for a Graves’ Disease Susceptibility Locus at Chromosome Xp11 in a United Kingdom Population1 | 4.5 | 54 | Citations (PDF) |
| 120 | Clinical Presentation and Natural History of Graves’ Ophthalmopathy | 0.0 | 3 | Citations (PDF) |
| 121 | Anti-thyroid drug treatment before radioiodine in patients with Graves' disease: soother or menace? | 2.5 | 12 | Citations (PDF) |
| 122 | Lack of Antigenicity of Recombinant Human Thyrotropin After Multiple Injections in Patients with Differentiated Thyroid Cancer | 4.7 | 8 | Citations (PDF) |
| 123 | Evidence for a New Graves Disease Susceptibility Locus at Chromosome 18q21 | 6.5 | 66 | Citations (PDF) |
| 124 | Optimizing the Management of Differentiated Thyroid Cancer | 1.4 | 5 | Citations (PDF) |
| 125 | The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus | 3.1 | 204 | Citations (PDF) |
| 126 | Severe Thyroid Eye Disease Associated with Primary Hypothyroidism and Thyroid-Associated Dermopathy | 4.7 | 21 | Citations (PDF) |
| 127 | Evaluation of serum markers of neuronal damage following severe hypoglycaemia in adults with insulin-treated diabetes mellitus | 5.0 | 29 | Citations (PDF) |
| 128 | Further Evidence for a Susceptibility Locus on Chromosome 20q13.11 in Families with Dominant Transmission of Graves Disease | 6.5 | 53 | Citations (PDF) |
| 129 | Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy | 14.8 | 122 | Citations (PDF) |
| 130 | Factors influencing preference of insulin regimen in people with type 1 (insulin–dependent) diabetes | 3.3 | 15 | Citations (PDF) |
| 131 | Natural History of Thyroid Eye Disease | 4.7 | 86 | Citations (PDF) |
| 132 | Clinical Presentation of Thyroid Associated Orbitopathy | 4.7 | 55 | Citations (PDF) |
| 133 | The Long-Term Sequelae of Severe Hypoglycemia on the Brain in Insulin-Dependent Diabetes Mellitus | 1.8 | 27 | Citations (PDF) |
| 134 | Brain Abnormalities Demonstrated by Magnetic Resonance Imaging in Adult IDDM Patients With and Without a History of Recurrent Severe Hypoglycemia | 9.6 | 133 | Citations (PDF) |
| 135 | An Audit of Waiting Times in the Diabetic Outpatient Clinic: Role of Patients’ Punctuality and Level of Medical Staffing | 3.1 | 15 | Citations (PDF) |
| 136 | Non-islet cell tumour-associated hypoglycaemia: 111
In-octreotide imaging and efficacy of octreotide, growth hormone and glucocorticosteroids | 2.5 | 58 | Citations (PDF) |
| 137 | Altered Taste Sensation in Newly-Diagnosed NIDDM | 9.6 | 82 | Citations (PDF) |
| 138 | Natural history of thyroid associated ophthalmopathy | 2.5 | 204 | Citations (PDF) |
| 139 | Thyroid-associated ophthalmopathy: pathogenesis and clinical management | 0.8 | 43 | Citations (PDF) |
| 140 | Chronic Pontine Dysfunction Following Insulin-Induced Hypoglycemia in an IDDM Patient | 9.6 | 20 | Citations (PDF) |
| 141 | Anti-mitochondrial antibodies in patients with Graves' disease may not signify primary biliary cirrhosis. | 1.9 | 1 | Citations (PDF) |
| 142 | Pathogenesis of thyroid-associated ophthalmopathy | 9.8 | 16 | Citations (PDF) |
| 143 | Autoantibodies to Igf-1 Binding Sites in Thyroid Associated Ophthalmopathy | 3.1 | 136 | Citations (PDF) |
| 144 | Psoas abscess due to retroperitoneal tuberculous lymphadenopathy | 0.8 | 8 | Citations (PDF) |
| 145 | Long-Term Effects of Hypoglycaemia on Cognitive Function and the Brain in Diabetes 0, , 285-307 | | 4 | Citations (PDF) |
| 146 | Thyroid Cancer 0, , 143-148 | | 0 | Citations (PDF) |
| 147 | Adrenal Cortical Carcinoma 0, , 137-141 | | 0 | Citations (PDF) |
| 148 | The Impact of Hypothyroidism on Satisfaction with Care and Treatment and Everyday Living: Results from E-Mode Patient Self-Assessment of Thyroid Therapy, a Cross-Sectional, International Online Patient Survey | 4.7 | 13 | Citations (PDF) |
| 149 | Patients’ persistent symptoms, clinician demographics and geo-economic factors are associated with choice of therapy for hypothyroidism by European thyroid specialists: The “THESIS”* collaboration
(*<i>T</i>reatment of <i>H</i>ypothyroidism in Europe by <i>S</i>pecialists, an <i>I</i>nternational <i>S</i>urvey) | 4.7 | 9 | Citations (PDF) |
